Sample Preparation by Mixed-Mode SPE Using ISOLUTE® HCX

Importance of the Topic

Mixed-mode solid-phase extraction (SPE) offers superior cleanup for trace analysis of basic drugs in complex biological matrices by combining hydrophobic and ion-exchange interactions. This approach addresses limitations of protein precipitation and conventional non-polar SPE, delivering high-purity extracts essential for sensitive downstream techniques like LC-MS.

Objectives and Study Overview

This technical note details a rigorous protocol for extracting basic analytes from plasma or urine using ISOLUTE® HCX mixed-mode SPE sorbents. Additionally, key material characteristics and preparative applications of RENSA® RP polymer resins are summarized to demonstrate their utility in broader purification workflows.

Methodology and Instrumentation

Sample pre-treatment involves diluting 100 µL of biofluid 1:1 with 0.05 M ammonium acetate buffer (pH 6.0). Using 25 mg/1 mL ISOLUTE HCX columns or 96-well plates on VacMaster vacuum manifolds, PRESSURE+96 positive-pressure manifolds, or automated platforms (Biotage Extrahera™), the sequence is:

• Conditioning with 1 mL methanol
• Equilibration with 250 µL ammonium acetate buffer (0.05 M, pH 6.0)
• Loading 200 µL buffered sample
• Sequential interference washes: 250 µL ammonium acetate buffer, 250 µL 1 M acetic acid, 250 µL methanol
• Elution of analytes with two 100 µL aliquots of methanol/ammonium hydroxide (95:5 v/v), 2–4 min soak each

Extracts are evaporated and reconstituted in appropriate mobile phase for LC-MS analysis.

Main Results and Discussion

The dual retention mechanism of ISOLUTE HCX effectively retains basic analytes while eliminating co-extracted neutral and acidic interferences. Capacity testing showed no breakthrough with up to 1 mL plasma spiked at 0.1 mg/mL. RENSA RP resins exhibit a uniform 90 µm particle size, 120 Å pore diameter, 1.2 mL/g pore volume, and ~340 m2/g surface area, delivering high-resolution preparative separations and robust cycling stability under process conditions.

Benefits and Practical Applications

• High-purity extracts for bioanalytical QC, pharmacokinetics, and toxicology
• Reduced matrix effects through targeted interference removal
• Scalable preparative separations for pharmaceuticals, food additives, peptides, and chemical intermediates using RENSA RP

Future Trends and Potential Applications

Emerging developments include integration of mixed-mode SPE with fully automated, high-throughput platforms; novel sorbent chemistries to expand analyte coverage (e.g., weak bases/acids); and scale-up of mixed-mode polymers for process-scale isolations in the pharmaceutical and chemical industries.

Conclusion

ISOLUTE HCX mixed-mode SPE provides a robust, selective workflow for extracting basic drugs from complex biological fluids, ensuring high-purity extracts for sensitive analyses. RENSA RP polymer resins complement this by offering durable, high-resolution preparative separations across diverse applications.

Reference

• Biotage Technical Note TN125.V.1
• Biotage Technical Note TN113.V.1